Gender Differences of Thromboembolic Events in Atrial Fibrillation (Q26765963)

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Sex, Stroke, and Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Validation of Clinical Classification Schemes for Predicting Stroke

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Gender differences in anticoagulation and antithrombotic therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Sex differences in stroke prevention in atrial fibrillation in French primary care. Results of the AFIGP (Atrial Fibrillation In General Practice) database

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Gender differences in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Effect of gender difference on platelet reactivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study)

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM).

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Impact of gender on the prognosis of patients with nonvalvular atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Does CHA2DS2-VASc improve stroke risk stratification in postmenopausal women with atrial fibrillation?

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation—A nation wide database analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Women with atrial fibrillation: Greater risk, less attention

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Risk of stroke and intracranial hemorrhage in 9727 Chinese with atrial fibrillation in Hong Kong.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Risk of cardiovascular and cerebrovascular events after atrial fibrillation diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Women hospitalized with atrial fibrillation: gender differences, trends and outcome from a 20-year registry in a Middle Eastern country (1991-2010).

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Relation of renal dysfunction to the increased risk of stroke and death in female patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Risk factors and incidence of stroke and MACE in Chinese atrial fibrillation patients presenting to emergency departments: a national wide database analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Gender differences of bleeding and stroke risk in very old atrial fibrillation patients on VKA treatment: results of the EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Risk factors for thromboembolism in patients with paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Apixaban in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Apixaban versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Associations of Plasma Fibrinogen Levels with Established Cardiovascular Disease Risk Factors, Inflammatory Markers, and Other Characteristics: Individual Participant Meta-Analysis of 154,211 Adults in 31 Prospective Studies: The Fibrinogen Studies C

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Stroke due to atrial fibrillation in a population-based stroke registry (Ludwigshafen Stroke Study) CHADS(2) , CHA(2) DS(2) -VASc score, underuse of oral anticoagulation, and implications for preventive measures

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Heart disease and stroke statistics--2014 update: a report from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Sex differences in management and outcome after stroke: a Swedish national perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Thrombosis and antithrombotic therapy in women

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Atrial fibrillation, stroke, and anticoagulation in Medicare beneficiaries: trends by age, sex, and race, 1992-2010.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Hyperthyroidism and risk of ischemic stroke in young adults: a 5-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

High von Willebrand factor levels increase the risk of stroke: the Rotterdam study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Atrial fibrillation and the risk of ischemic stroke: does it still matter in patients with a CHA2DS2-VASc score of 0 or 1?

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Comparison of clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Modification of outcomes with aspirin or apixaban in relation to female and male sex in patients with atrial fibrillation: a secondary analysis of the AVERROES study

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Thromboembolic event rate in paroxysmal and persistent atrial fibrillation: data from the GISSI-AF trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Stroke and thromboembolism in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

The link between atrial fibrillation and stroke in women

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021

Lessons from the Stroke Prevention in Atrial Fibrillation trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.AMJCARD.2015.12.040

7 January 2021